Carbamyl-Lysine (CBL) Antibody – Goat Polyclonal

• Affinity purified at 0.5 mg/mL

Carbamylation is a post-translational modification which occurs throughout the lifespan of proteins in vivo. Carbamylation results from the binding of isocyanic acid, spontaneously derived from high concentrations of urea and leading to the formation of carbamyl-lysine (CBL) (Figure 1). The carbamylation of proteins is usually associated with a partial or complete loss of protein function. It is known that elevated urea directly induces the formation of potentially atherogenic carbamylated LDL (cLDL). High blood concentrations of urea leading to the carbamylation process were detected in uremic patients and patients with end-stage renal disease.

Small volumes of anti-Carbamyl-Lysine (CBL) antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS168978 is an antibody targeting Carbamyl-Lysine (CBL). Also known as Goat Anti-Carbamyl-Lysine (CBL) Polyclonal Antibody. Reactive in Any. Host: Goat.